Integrating CRISPR/Cas systems with programmable DNA nanostructures for delivery and beyond

iScience. 2022 May 11;25(6):104389. doi: 10.1016/j.isci.2022.104389. eCollection 2022 Jun 17.


Precise genome editing with CRISPR/Cas paves the way for many biochemical, biotechnological, and medical applications, and consequently, it may enable treatment of already known and still-to-be-found genetic diseases. Meanwhile, another rapidly emerging field-structural DNA nanotechnology-provides a customizable and modular platform for accurate positioning of nanoscopic materials, for e.g., biomedical uses. This addressability has just recently been applied in conjunction with the newly developed gene engineering tools to enable impactful, programmable nanotechnological applications. As of yet, self-assembled DNA nanostructures have been mainly employed to enhance and direct the delivery of CRISPR/Cas, but lately the groundwork has also been laid out for other intriguing and complex functions. These recent advances will be described in this perspective.

PMID:35633938 | PMC:PMC9130510 | DOI:10.1016/j.isci.2022.104389


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *